• deplazio
    The Department of Epidemiology of the Lazio Regional Health Service (DEP)
    is based in Rome and has over 30 years of experience
  • ambientale-valutativo

    The staff of the DEP has specific expertise in epidemiological methods
  • rischi ambientali
    Provide decision makers with the best epidemiological evidence
    to plan interventions to reduce health risks
  • esiti
    Outcome evaluation of health care
  • cure sanitarie
    Provide evidence to improve the quality
    and effectiveness of health care
  • inquinamento
    Assess the risks associated with
    short and long term exposure to air pollutants
  • cambiamenti climatici
    Assessing the health impact of climate change and extreme events

Registro Regionale Dialisi e Trapianti Lazio (RRDTL)

Cochrane Drugs and Alcohol Group PDF Print E-mail

cochrane newCochrane is an international network made up of professionals, health care administrators and users interested in preparing, updating and disseminating systematic revisions of primary studies on the effects of health care.

Cochrane develops its activities through Collaborative Review Groups, which - at international level - collaborate in this common goal. In addition to the work done by the Groups, Cochrane uses Method Groups (GM) - whose task is to do research on the methodology of systematic reviews and the issues related to it - and Fields / Networks that promote coordination between the various GCR and the collection of relevant studies for the production of systematic reviews.

The main product of Cochrane is the Cochrane Library, which contains six databases including the Cochrane Database of Systematic Reviews (CDSR). The CDSR collects all the systematic reviews produced by the Cochrane Collaboration as well as the protocols of the reviews in progress. The CDSR in 2015 had an impact factor of 6032.

The Cochrane Drugs and Alcohol Group is one of the 54 Cochrane groups and is responsible for conducting systematic reviews of trials on the prevention, treatment and rehabilitation of the problematic use of psychoactive substances. The Group has so far published 79 systematic reviews and 21 protocols, and has also 14 recorded titles.

 

Our Activities

 

To Know more